User profiles for Wolfgang A Weber
 | Wolfgang WeberProfessor of Nuclear Medicine Technical University of Munich Verified email at tum.de Cited by 42769 |
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
WA Weber, K Ott, K Becker, HJ Dittler… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: Preoperative chemotherapy in patients with gastroesophageal cancer is
hampered by the lack of reliable predictors of tumor response. This study evaluates whether …
hampered by the lack of reliable predictors of tumor response. This study evaluates whether …
Positron emission tomography in non–small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use
WA Weber, V Petersen, B Schmidt… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To prospectively evaluate the use of positron emission tomography with the glucose
analog fluorodeoxyglucose (FDG-PET) to predict response to chemotherapy in patients …
analog fluorodeoxyglucose (FDG-PET) to predict response to chemotherapy in patients …
Positron emission tomography as an imaging biomarker
WA Weber - Journal of Clinical Oncology, 2006 - ascopubs.org
Positron emission tomography (PET) allows noninvasive, quantitative studies of various
biologic processes in the tumor tissue. By using PET, investigators can study the …
biologic processes in the tumor tissue. By using PET, investigators can study the …
[HTML][HTML] FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting
and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET …
and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET …
[PDF][PDF] Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in …
… Weber, Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josee M. … Weber,
Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josee M. … Allen-Auerbach M …
Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josee M. … Allen-Auerbach M …
[HTML][HTML] FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
R Boellaard, MJ O'Doherty, WA Weber… - European journal of …, 2010 - Springer
The aim of this guideline is to provide a minimum standard for the acquisition and interpretation
of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will …
of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will …
Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04
…, T Sun, SG Nekolla, A Richter, C Weber… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Heart failure remains a major source of late morbidity and mortality after myocardial infarction
(MI). The temporospatial presence of activated fibroblasts in the injured myocardium …
(MI). The temporospatial presence of activated fibroblasts in the injured myocardium …
Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography
R Haubner, HJ Wester, WA Weber, C Mang, SI Ziegler… - Cancer research, 2001 - AACR
The α v β 3 integrin is an important cell adhesion receptor involved in tumor-induced
angiogenesis and tumor metastasis. Here we describe the 18 F-labeling of the RGD-containing …
angiogenesis and tumor metastasis. Here we describe the 18 F-labeling of the RGD-containing …
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
…, H Su, IJ Hildebrandt, WA Weber… - Proceedings of the …, 2007 - National Acad Sciences
Targeted delivery represents a promising approach for the development of safer and more
effective therapeutics for oncology applications. Although macromolecules accumulate …
effective therapeutics for oncology applications. Although macromolecules accumulate …
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
Background In patients with locally advanced adenocarcinoma of the oesophagogastric
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([ 18 F]FDG-…
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([ 18 F]FDG-…